ABP-7 Peptide (10mg)
ABP-7 10 mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 10 mg of pure ABP-7 per vial, this product undergoes rigorous third-party analytical testing to confirm optimal sequence integrity and purity exceeding 99%. ABP-7 is utilized in advanced biological and biochemical research models investigating cellular signaling pathways, protein interaction kinetics, and tissue-specific receptor dynamics.
Key Specifications
Ā Active Compound: ABP-7
Ā Concentration: 10 mg per vial
Ā Purity Standard: Exceeds 99% (Third-Party HPLC & Mass Spectrometry Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Cellular Signaling & Receptor Interactions: Utilized in in-vitro models to study ligand-receptor binding affinity, intracellular cascade activation, and cell membrane interaction dynamics.
Ā Biochemical & Molecular Analysis: Engineered for laboratory assays requiring high structural stability, consistent molecular weight verification, and minimal lot-to-lot variability.
Ā Tissue & Metabolic Dynamics: Investigated in specialized cellular protocols focusing on protein synthesis pathways and targeted cellular response mechanisms.
ACE-031 Peptide (1mg)
ACE-031 1 mg is a research-grade lyophilized protein peptide engineered for high-purity laboratory applications. Each vial contains 1 mg of HPLC-verified ACE-031, third-party tested to guarantee over 99% purity and manufactured in the USA under strict standards. Formulated specifically for research investigating myostatin signal neutralization, ActRIIB decoy receptor binding, and muscle growth regulation pathways, this product is strictly intended for research use only.
Acetyl Hexapeptide-3 (Argireline) (200mg)
Acetyl Hexapeptide-3 provides 200 mg of high-purity, laboratory-verified synthetic peptide in a sterile research vial. Commonly known as Argireline, this synthetic hexapeptide is widely studied in cosmetic science and dermatological research for its ability to target neurotransmitter release mechanisms and inhibit SNARE complex formation. Formulated with a purity exceeding 99%, it delivers high analytical consistency for cellular studies evaluating topical elasticity, dermal matrix stability, and muscle contraction inhibition. Strictly for laboratory research use only.
Adipotide (FTPP) (10mg)
Adipotide FTPP provides 10 mg of laboratory-grade Fat Targeting Pro-apoptotic Peptide in a sterile, lyophilized vial. Engineered to target prohibitin receptors in white adipose tissue vasculature, this high-purity peptidomimetic (>99% purity) is widely studied in metabolic research for inducing targeted vascular apoptosis and rapid adipose regression. Strictly for laboratory research use only.
AHK-Cu (200mg)
AHK-Cu is a peptide composed of amino acids alanine, histidine, and lysine, with a copper ion coordinated by various parts of these three amino acids.(1) This peptide appears to be naturally present in the bloodstream and has been suggested as a potential element in regulating the growth, development, and apoptosis of vascular endothelial cells.
Size: 200mg
Contents: AHK-Cu
Form: Lyophilized powder
Purity: >99%
SKU: P-AHK-CU
AICAR Peptide (50mg)
AICAR 50 mg provides a high-purity, laboratory-verified lyophilized compound manufactured under strict quality control standards in the USA. Formulated with 50 mg of pure AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide) per vial, this synthetic adenosine analog is widely utilized in cellular, metabolic, and exercise physiology research investigating AMP-activated protein kinase (AMPK) activation, cellular energy homeostasis, and mitochondrial biogenesis pathways.
Key Specifications
Ā Active Compound: AICAR (Acadesine / AICA Riboside)
Ā Chemical Formula: \text{C}_{9}\text{H}_{15}\text{N}_{4}\text{O}_{8}\text{P}
Ā Concentration: 50 mg per vial
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā AMP-Activated Protein Kinase (AMPK) Activation: AICAR is intracellularly phosphorylated into ZMP, an AMP mimic that directly activates AMPK without altering cellular ATP/ADP ratios, facilitating targeted metabolic research.
Ā Mitochondrial Biogenesis & Endurance Pathways: Applied in cell cultures to analyze upregulated PGC-1$\alpha$ signaling, glucose uptake enhancement, and lipid oxidation mechanisms.
Ā Ischemic & Cellular Energy Homeostasis Studies: Extensively investigated in cardiac and skeletal muscle models measuring metabolic adaptation, cellular stress response, and insulin sensitivity.
AOD 9604 (5mg)
AOD 9604 5mg is a premium, high-purity (\ge99% HPLC-verified) synthetic analog of the C-terminal region of human growth hormone (hGH 177-191). Engineered specifically to isolate lipolytic receptor activity without elevating IGF-1 levels or altering glucose metabolism, AOD 9604 is an essential tool for laboratory studies targeting lipid metabolism, adipocyte signaling, and cartilage matrix regeneration. Supplied as a sterile lyophilized powder strictly for scientific research use.
ARA-290 Peptide (16mg)
ARA-290 16 mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 16 mg of pure ARA-290 (Cibinetide; Pyroglu-Glu-Gln-Glu-Arg-Glu-Arg-Ala-Glu-Ala-Lys-Glu)āa 11-amino-acid synthetic peptide derived from the erythropoietin (EPO) structureāthis compound selectively targets the Innate Repair Receptor (IRR) without stimulating erythropoiesis. It is widely utilized in neurology, immunology, and tissue regeneration research investigating neuropathic pain attenuation, small nerve fiber regeneration, and inflammatory cytokine suppression.
Key Specifications
Active Compound: ARA-290 (Cibinetide / Pyroglutamate Helix B Surface Peptide)
Chemical Formula: \text{C}_{51}\text{H}_{84}\text{N}_{16}\text{O}_{21}
Concentration: 16 mg per vial
Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Formulation: Sterile Lyophilized Powder
Origin: Manufactured in USA
Classification: Research Use Only
Primary Research Applications
Selective Innate Repair Receptor (IRR) Activation: ARA-290 selectively binds the erythropoietin receptor / \beta-common receptor (\text{EPOR/}\beta\text{cR}) heterodimer to initiate anti-inflammatory and tissue-protective signaling without increasing red blood cell count or hematocrit levels.
Small Fiber Neuropathy & Peripheral Nerve Repair: Extensively studied in neuropathic disease models for its ability to promote small nerve fiber density restoration, repair damaged peripheral axons, and relieve neuropathic pain signaling.
Anti-Inflammatory & Ischemic Protection: Investigated for its inhibitory effects on pro-inflammatory cytokine cascades (\text{TNF-}\alpha, \text{IL-6}) and its protective role against ischemia-reperfusion injury in cardiovascular and metabolic tissue models.
B7-33 (6mg)
B7-33 6 mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 6 mg of pure B7-33āa single-chain synthetic peptide functional analog of human gene-2 relaxin (H2 relaxin)āthis compound is widely utilized in cardiovascular, nephrology, and matrix biology research examining selective RXFP1 receptor signaling, extracellular matrix (ECM) remodeling, and anti-fibrotic signaling pathways without inducing tumor growth pathways.
Key Specifications
Active Compound: B7-33 (Relaxin-2 Receptor Agonist)
Chemical Formula: \text{C}_{136}\text{H}_{210}\text{N}_{40}\text{O}_{41}
Concentration: 6 mg per vial
Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Formulation: Sterile Lyophilized Powder
Origin: Manufactured in USA
Classification: Research Use Only
Primary Research Applications
Targeted Anti-Fibrotic Activity: B7-33 acts through the RXFP1 receptor to upregulate matrix metalloproteinases (MMPs) and suppress excessive collagen deposition, providing a targeted model for reversal of organ fibrosis.
Cardiovascular & Renal Remodeling: Extensively evaluated in preclinical models of heart failure, renal scarring, and vascular stiffness to assess hemodynamic regulation and arterial compliance enhancement.
Biasing RXFP1 Receptor Signaling: Investigated for its ability to preferentially stimulate pERK signaling over cAMP accumulation, preventing unwanted inotropic or proliferative side effects associated with full-length native relaxin.